Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$117M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$36.3M |
| 3 |
Becton Dickinson
BDX
|
+$30.5M |
| 4 |
Alibaba
BABA
|
+$29.1M |
| 5 |
NXP Semiconductors
NXPI
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$443M |
| 2 |
Microsoft
MSFT
|
+$315M |
| 3 |
Amazon
AMZN
|
+$275M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Industrials | 10.43% |
| 5 | Communication Services | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEL
1751
DELISTED
Belmond Ltd.
BEL
| $1.69M | ﹤0.01% |
151,400
+7,300
| +5% | +$89.7K |
|
1752
Kinsale Capital Group
KNSL
$8.59B
| $1.69M | ﹤0.01% |
32,862
+600
| +2% | +$29K |
|
1753
NovoCure
NVCR
$2.02B
| $1.69M | ﹤0.01% |
77,400
+3,700
| +5% | +$79.6K |
|
|
QUOT
1754
DELISTED
Quotient Technology Inc
QUOT
| $1.69M | ﹤0.01% |
128,800
+7,900
| +7% | +$100K |
|
1755
Usana Health Sciences
USNA
$252M
| $1.68M | ﹤0.01% |
19,600
| – | – |
|
|
DPLO
1756
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.68M | ﹤0.01% |
83,400
+5,500
| +7% | +$128K |
|
|
GZT
1757
DELISTED
Gazit-globe Ltd
GZT
| $1.68M | ﹤0.01% |
169,896
+4,431
| +3% | +$44.8K |
|
|
USCR
1758
DELISTED
U S Concrete, Inc.
USCR
| $1.68M | ﹤0.01% |
27,800
+2,100
| +8% | +$156K |
|
|
ARR
1759
Armour Residential REIT
ARR
$2.37B
| $1.68M | ﹤0.01% |
14,402
+800
| +6% | +$93.4K |
|
|
LABL
1760
DELISTED
Multi-Color Corp
LABL
| $1.67M | ﹤0.01% |
25,300
+1,300
| +5% | +$92.3K |
|
|
BEAT
1761
DELISTED
BioTelemetry, Inc.
BEAT
| $1.66M | ﹤0.01% |
53,600
+2,800
| +6% | +$92.1K |
|
1762
Manitowoc
MTW
$753M
| $1.66M | ﹤0.01% |
58,250
+1,700
| +3% | +$58.3K |
|
|
ACH
1763
Accendra Health
ACH
$84.6M
| $1.66M | ﹤0.01% |
106,600
+5,200
| +5% | +$92.7K |
|
1764
First Bancorp
FBNC
$2.74B
| $1.65M | ﹤0.01% |
46,400
+1,300
| +3% | +$46.9K |
|
1765
CBIZ
CBZ
$2.96B
| $1.65M | ﹤0.01% |
90,400
+1,700
| +2% | +$29.6K |
|
|
VNTR
1766
DELISTED
Venator Materials PLC
VNTR
| $1.65M | ﹤0.01% |
91,200
| – | – |
|
|
TYPE
1767
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.65M | ﹤0.01% |
73,500
| – | – |
|
1768
Precigen
PGEN
$2.32B
| $1.65M | ﹤0.01% |
107,500
| – | – |
|
|
ATRI
1769
DELISTED
Atrion Corp
ATRI
| $1.64M | ﹤0.01% |
2,602
| – | – |
|
1770
Radware
RDWR
$1.25B
| $1.64M | ﹤0.01% |
76,900
+4,100
| +6% | +$85K |
|
1771
St. Joe Company
JOE
$3.89B
| $1.63M | ﹤0.01% |
86,400
| – | – |
|
|
JCP
1772
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.63M | ﹤0.01% |
539,300
+10,000
| +2% | +$36.1K |
|
1773
MacroGenics
MGNX
$259M
| $1.63M | ﹤0.01% |
64,700
+5,100
| +9% | +$124K |
|
1774
BancFirst
BANF
$3.89B
| $1.62M | ﹤0.01% |
30,518
+1,400
| +5% | +$76.5K |
|
1775
Iridium Communications
IRDM
$5.27B
| $1.62M | ﹤0.01% |
144,100
+2,700
| +2% | +$32.3K |
|
Similar funds
Swiss National Bank's Q1 2018 Portfolio in Review
As of Q1 2018, Swiss National Bank held 2,520 positions worth $82B, down 11% from $92.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank withdrew a net $9.58B in Q1 2018, closing 36 positions and reducing 634 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Nutrien worth $111M.
- Swiss National Bank's largest Q1 2018 buy was Nutrien: 2,341,052 shares worth $111M.
- Swiss National Bank added most to Worldpay, Inc. in Q1 2018, an estimated $36.3M increase.
- Swiss National Bank's biggest Q1 2018 reduction was Apple, cutting an estimated $443M.
- Swiss National Bank fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $66.5M.
- Swiss National Bank's ten largest holdings make up 17% of its $82B portfolio in Q1 2018.
- Swiss National Bank opened 6 new positions and closed 36 in Q1 2018.
- Swiss National Bank's portfolio value fell 11% quarter-over-quarter to $82B.
Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.